Area of research
Surgery · Cancer Research
Research interest
Research focused on Bladder cancer and Breast cancer, with related work in Renal cell carcinoma, Meiosis, Concomitant. Notable publications include 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†', 'EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and...', and 'Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer'.
Ultrastaging Confirms the Superior Sensitivity of Quantitative Immunocytology for Detection of Lymph Node Spread in Non–Small Cell Lung Cancer Patients
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers
Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial Cancer
Vergleich immunologischer Biomarker in Primärtumoren und Metastasen von Brustkrebspatientinnen
Noninferiority of Artificial Intelligence–Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics
Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes
Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint Inhibition
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma
Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche
Transurethral <i>en bloc</i> submucosal hydrodissection vs conventional resection for resection of non‐muscle‐invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial
Abstract PR04: Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years
ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ
c-Met in chromophobe renal cell carcinoma
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression
Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size
The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma
Small renal cell carcinomas – How dangerous are they really? Results of a large multicenter study
<b><i>Mdm2</i></b> SNP309 G-Variant Is Associated with Invasive Growth of Human Urinary Bladder Cancer
Abstract 2017: Exome sequencing reveals novel mutations in a GIST and a paraganglioma occurring simultaneously in a patient with complete form of Carney triad.
Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer
Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria